Shalby Hospitals Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks

The Shalby Hospitals share price target for 2026 stands at Rs 278 as per the latest analyst forecast, implying 29 percent upside from the current market price of Rs 215. Investors tracking the Shalby Hospitals share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the Shalby Hospitals share price target thesis updated April 2026.

Click Here to Get Free Investment Predictions on Univest

Track live Shalby Hospitals price, FII or DII flows and analyst targets on the Univest Screener.

Shalby Hospitals Company Overview

Tap to Access Best Research on Univest

Shalby Hospitals (NSE: SHALBY) is a listed company in India’s Hospitals sector with a market capitalisation of Rs 2795 crore. At CMP Rs 215 against a 52 week range of Rs 172 to Rs 255, the stock currently offers meaningful upside to the analyst price forecast of Rs 278. For more share price target analysis, visit Univest Blogs.

Parameter	Value
NSE Ticker	SHALBY
Sector	Hospitals
CMP April 2026	Rs 215
52 Week High	Rs 255
52 Week Low	Rs 172
Market Cap	Rs 2795 crore
Trailing P/E	22x
12M Analyst Price Forecast	Rs 278
Bull Case Target	Rs 334
Bear Case Target	Rs 163

Why Analysts Set the Shalby Hospitals Share Price Target at Rs 278 for 2026

FY27 Earnings Delivery and Revenue Acceleration

FY27 is the key year where analysts expect Shalby Hospitals to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 215 and the Shalby Hospitals share price target 2026 of Rs 278. Analysts project 15 to 20 percent PAT growth in FY27. Track Q4 results live on the Univest Screener.

Government capex allocation boosting order book

Government capex allocation boosting order book is a key growth driver that analysts highlight in supporting the Shalby Hospitals share price target of Rs 278. The Hospitals sector is expanding at 12 to 18 percent annually, and Shalby Hospitals is well-positioned to capture a rising share. Discover top Hospitals stocks on the Univest Screener.

PSU bank credit growth supporting expansion

PSU bank credit growth supporting expansion provides an additional lever that can help Shalby Hospitals exceed analyst projections and potentially push the stock toward the bull case target of Rs 334. Compare Shalby Hospitals with sector peers on the Univest Screener.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s rate cut cycle that commenced in 2026 reduces Shalby Hospitals’s borrowing costs and stimulates end-market demand, supporting the Shalby Hospitals share price target 2026 of Rs 278.

Union Budget 2026-27 Policy Support

Budget 2026-27 capex continuity and PLI scheme extensions create a constructive backdrop for Shalby Hospitals’s Hospitals business, directly supporting the Shalby Hospitals share price target 2026 bull case of Rs 334.

Bull Case, Base Case and Bear Case for Shalby Hospitals Share Price Target

Scenario	Target	Key Assumption
Bull Case	Rs 334	FY27 revenue growth exceeds 25 percent, margin expansion of 200 bps, sector re-rating
Base Case Forecast	Rs 278	FY27 revenue growth of 15 to 18 percent, stable margins, current P/E sustained
Bear Case	Rs 163	Revenue growth disappoints below 10 percent, margin pressure, valuation de-rating

For live tracking of Shalby Hospitals analyst price targets and ratings, use the Univest Screener.

Key Risks to the Shalby Hospitals Share Price Target

Earnings Miss Risk

If Shalby Hospitals reports quarterly earnings below expectations, the Shalby Hospitals share price target will likely face downward revision. Watch Q4 FY26 results closely on Univest Screener.

Macro and Global Headwinds

The US 26 percent reciprocal tariff announcement of April 2026 has created global macro uncertainty that adds near-term risk to the Shalby Hospitals share price target 2026 timeline.

Sector-Specific Risks

Regulatory changes, input cost volatility, and competitive intensity in the Hospitals space could pressure margins and delay realisation of the Shalby Hospitals share price target of Rs 278.

FII Outflows

Continued FII selling in Indian equities could suppress the valuation multiples needed for Shalby Hospitals to reach its analyst price forecast of Rs 278 within the 12 month horizon.

Shalby Hospitals Financial Snapshot FY25 to FY27

Metric	FY25 Actual	FY26 Estimate	FY27 Estimate
Revenue (Rs Cr)	Refer NSE filing	Refer NSE filing	Refer NSE/BSE filing
EBITDA Margin	Refer NSE filing	Refer NSE filing	Expected expansion
PAT (Rs Cr)	Refer NSE filing	Refer NSE filing	15 to 20 percent growth
Market Cap	Rs 2795 crore	Higher at 52W peak	Tracks price movement
P/E Ratio	22x	Current level	Target implies re-rating
52 Week High / Low	Rs 255 / Rs 172

If you want to track Shalby Hospitals financial metrics, analyst ratings and peer comparisons in real time, check the Univest Screener for live data.

Technical Outlook for Shalby Hospitals Share Price

Shalby Hospitals is trading at Rs 215, currently attempting to build a base above its 52 week low of Rs 172. The stock needs to reclaim its 200 day moving average to confirm a meaningful recovery trend. The Shalby Hospitals share price target of Rs 278 set by analysts assumes fundamental delivery over the next 12 months rather than near-term price action. Download the Univest iOS App or Univest Android App to track Shalby Hospitals live price and set alerts.

Conclusion

The Shalby Hospitals share price target 2026 of Rs 278 reflects analyst conviction on FY27 earnings delivery, structural sector tailwinds, and the favourable domestic macro environment. The bull case of Rs 334 is achievable if the company executes above expectations. Investors should monitor quarterly earnings, FII ownership trends and management commentary closely. For real-time tracking and research, use the Univest Screener.

This article is for informational and educational purposes only and is not investment advice. Univest is SEBI registered (INH000013776). Please consult a SEBI registered financial advisor before making any investment decision.

Frequently Asked Questions

What is the Shalby Hospitals share price target for 2026?

The Shalby Hospitals share price target for 2026 is Rs 278 as per the analyst price forecast, implying 29 percent upside from the current price of Rs 215. The bull case target is Rs 334 and the bear case is Rs 163.

Is Shalby Hospitals a good buy at Rs 215?

At Rs 215, Shalby Hospitals trades at a trailing P/E of 22x and offers potential upside to the analyst price forecast of Rs 278. Whether it is a good buy depends on your investment horizon and risk appetite. Always consult a SEBI registered financial advisor.

What is the 52 week high and low of Shalby Hospitals?

The 52 week high of Shalby Hospitals is Rs 255 and the 52 week low is Rs 172. The current CMP of Rs 215 positions the stock at a meaningful discount to its peak, which is factored into the analyst Shalby Hospitals share price target 2026.

What sector does Shalby Hospitals belong to?

Shalby Hospitals belongs to India’s Hospitals sector and trades on NSE with the ticker SHALBY. Track the entire Hospitals sector on the Univest Screener.

What is the bull case for Shalby Hospitals share price?

The bull case for Shalby Hospitals share price is Rs 334, which assumes revenue growth exceeding 25 percent in FY27, margin expansion of 200 basis points, and a positive re-rating of the Hospitals sector. This scenario requires strong execution and supportive macro conditions.

What are the key risks to the Shalby Hospitals share price target?

Key risks include earnings miss in upcoming quarters, continued FII selling, regulatory headwinds in the Hospitals sector, raw material cost volatility, and global macro uncertainty driven by the US tariff environment. These risks could push the stock toward the bear case of Rs 163.

Recent Article

United Breweries Q4 Results FY26: PAT Rs 102 Crore on Strong Kingfisher Beer Summer Season Volumes

Ambuja Cement Share Price Target 2026: Analyst Consensus, Growth Catalysts and Key Risks

Voltamp Transformers Q4 Results FY26: PAT Rs 48 Crore on Industrial Transformer Demand from Core Sectors

Marico Q4 Results FY26: PAT Rs 391 Crore, Revenue Rs 3333 Crore Up 22 Percent, Dividend Up 30 Percent

Raymond Realty Q4 Results FY26: PAT Rs 161 Crore on Strong Thane Residential Project Sales